Delhi fake drug racket targets J&J and GSK products
Delhi authorities have busted a massive counterfeit drug operation, with fake versions of Johnson & Johnson and GSK products seized. The racket poses serious health risks to consumers.
Delhi authorities have busted a massive counterfeit drug operation, with fake versions of Johnson & Johnson and GSK products seized. The racket poses serious health risks to consumers.
The US Food and Drug Administration (FDA) has approved a new Alzheimer's treatment, sparking debate over its efficacy and high cost while offering hope to millions.
Shares in major European pharmaceutical firms plummet as investors react to potential US tariffs, sparking market volatility and sector-wide uncertainty.
Sales of Novo Nordisk's blockbuster diabetes medications, including Ozempic, have dropped unexpectedly. Experts weigh in on the causes and future implications.
Former US President Donald Trump has floated the idea of imposing tariffs on imported pharmaceuticals, a move that could significantly impact the UK's healthcare sector and drug prices.
Former President Donald Trump’s controversial proposal to slash drug prices has reignited tensions with pharmaceutical giants. Critics warn of risks to innovation, while advocates hail it as a win for patients.
Liam Neeson's sister-in-law has given her blessing to his new relationship, saying the actor 'deserves happiness' after years of heartache following the death of his wife Natasha Richardson.
Labour leader Keir Starmer vows to confront pharmaceutical giants over soaring drug prices, promising relief for the NHS and patients. Will his strategy work?
Former US President Donald Trump calls on British pharmaceutical companies to reduce drug prices for the NHS, sparking debate on healthcare affordability.
New US tariffs could drastically increase the cost of essential medicines in Australia, putting the Pharmaceutical Benefits Scheme at risk. Experts warn of dire consequences for patients.
Biotech leader Moderna announces major layoffs, axing 150 jobs as part of a strategic cost-reduction plan. What does this mean for the future of mRNA vaccines?
Former US President Donald Trump's approval ratings have taken a hit in a recent poll, raising questions about his political future ahead of the 2024 election.
Prime Minister Anthony Albanese enjoys solid approval ratings as he starts his second term, but the potential return of Donald Trump to the White House could reshape Australia’s political landscape.
A new survey reveals declining support for Donald Trump, raising questions about his potential 2024 presidential bid. Dive into the numbers and key takeaways.
AstraZeneca's CEO highlights the critical role of the US market amid looming Trump tariffs, emphasising the need for stable trade policies to sustain pharmaceutical innovation.
Novo Nordisk's blockbuster weight-loss drug Wegovy drives record sales, boosting shares and intensifying competition with Eli Lilly.
Pharmaceutical giant AstraZeneca faces a sharp decline in share prices following an unfavourable US court ruling, sparking investor concerns.
A new YouGov poll reveals Jeremy Corbyn's surprising lead over Keir Starmer in public approval, raising questions about Labour's future direction.
A US couple has been sentenced after authorities discovered their home packed with illegal erectile dysfunction drugs worth thousands.
Recent polling data shows a sharp decline in Donald Trump's approval ratings, raising questions about the sustainability of the MAGA movement.
A recent survey by the Office for National Statistics shows a significant decline in public trust in the UK government. Experts weigh in on the causes and implications.
A new poll shows Prince Harry and Meghan Markle's approval ratings in the UK have hit an all-time low. Discover why Brits are turning against the Sussexes.
Former US President Donald Trump's approval ratings among male voters have seen a significant decline, raising questions about shifting political loyalties ahead of the next election.
New polling data reveals a surprising drop in Donald Trump's approval ratings among men, signalling potential trouble for his 2024 campaign. Experts weigh in on the possible reasons.
Former US President Donald Trump has seen his highest approval ratings in months, defying expectations amid ongoing controversies. Experts weigh in on the surprising resilience of his political support.
Pharmaceutical giant AstraZeneca announces a bold $1.5bn US expansion despite looming tariff threats from the Trump administration, signalling confidence in transatlantic trade resilience.
Japanese Prime Minister Fumio Kishida vows to stay in office despite a sharp decline in public support, as his party faces mounting criticism over economic policies and political scandals.
A parliamentary report reveals systemic gender bias in NHS drug approvals, leaving women without critical treatments available elsewhere in Europe.